Literature DB >> 25368031

Activation of D4 dopamine receptor decreases angiotensin II type 1 receptor expression in rat renal proximal tubule cells.

Ken Chen1, Kun Deng1, Xiaoyan Wang1, Zhen Wang1, Shuo Zheng1, Hongmei Ren1, Duofen He1, Yu Han1, Laureano D Asico1, Pedro A Jose1, Chunyu Zeng2.   

Abstract

The dopaminergic and renin-angiotensin systems interact to regulate blood pressure. Disruption of the D4 dopamine receptor gene in mice produces hypertension that is associated with increased renal angiotensin type 1 (AT1) receptor expression. We hypothesize that the D4 receptor can inhibit AT1 receptor expression and function in renal proximal tubule cells from Wistar-Kyoto (WKY) rats, but the D4 receptor regulation of AT1 receptor is aberrant in renal proximal tubule cells from spontaneously hypertensive rats (SHRs). The D4 receptor agonist, PD168077, decreased AT1 receptor protein expression in a time- and concentration-dependent manner in WKY cells. By contrast, in SHR cells, PD168077 increased AT1 receptor protein expression. The inhibitory effect of D4 receptor on AT1 receptor expression in WKY cells was blocked by a calcium channel blocker, nicardipine, or calcium-free medium, indicating that calcium is involved in the D4 receptor-mediated signaling pathway. Angiotensin II increased Na(+)-K(+) ATPase activity in WKY cells. Pretreatment with PD168077 decreased the stimulatory effect of angiotensin II on Na(+)-K(+) ATPase activity in WKY cells. In SHR cells, the inhibitory effect of D4 receptor on angiotensin II-mediated stimulation of Na(+)-K(+) ATPase activity was aberrant; pretreatment with PD168077 augmented the stimulatory effect of AT1 receptor on Na(+)-K(+) ATPase activity in SHR cells. This was confirmed in vivo; pretreatment with PD128077 for 1 week augmented the antihypertensive and natriuretic effect of losartan in SHRs but not in WKY rats. We suggest that an aberrant interaction between D4 and AT1 receptors may play a role in the abnormal regulation of sodium excretion in hypertension.
© 2014 American Heart Association, Inc.

Entities:  

Keywords:  angiotensin type 1 receptor; dopamine D4 receptor; hypertension

Mesh:

Substances:

Year:  2014        PMID: 25368031      PMCID: PMC4268176          DOI: 10.1161/HYPERTENSIONAHA.114.04038

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  32 in total

1.  Differential D1 and D5 receptor regulation and degradation of the angiotensin type 1 receptor.

Authors:  John J Gildea; Xiaoli Wang; Pedro A Jose; Robin A Felder
Journal:  Hypertension       Date:  2008-01-02       Impact factor: 10.190

2.  Elevation of [Ca2+]i of renal proximal tubular cells and down-regulation of mRNA of PTH-PTHrP, V1a and AT1 receptors in kidney of diabetic rats.

Authors:  W Marcinkowski; G Zhang; M Smogorzewski; S G Massry
Journal:  Kidney Int       Date:  1997-06       Impact factor: 10.612

3.  ATP stimulates Na+-glucose cotransporter activity via cAMP and p38 MAPK in renal proximal tubule cells.

Authors:  Yun Jung Lee; Soo Hyun Park; Ho Jae Han
Journal:  Am J Physiol Cell Physiol       Date:  2005-07-13       Impact factor: 4.249

4.  Effects of selective dopamine receptor subtype agonists on cardiac contractility and regional haemodynamics in rats.

Authors:  James S Polakowski; Jason A Segreti; Bryan F Cox; Gin C Hsieh; Teodozyj Kolasa; Robert B Moreland; Jorge D Brioni
Journal:  Clin Exp Pharmacol Physiol       Date:  2004-12       Impact factor: 2.557

5.  Low sodium intake induces an increase in renal monoamine oxidase activity in the rat. Involvement of an angiotensin II dependent mechanism.

Authors:  V De Luca Sarobe; S Nowicki; A Carranza; G Levin; M Barontini; E Arrizurieta; F R Ibarra
Journal:  Acta Physiol Scand       Date:  2005-10

6.  Activation of D3 dopamine receptor decreases angiotensin II type 1 receptor expression in rat renal proximal tubule cells.

Authors:  Chunyu Zeng; Yan Liu; Zheng Wang; Duofen He; Lan Huang; Peiying Yu; Shaopeng Zheng; John E Jones; Laureano D Asico; Ulrich Hopfer; Gilbert M Eisner; Robin A Felder; Pedro A Jose
Journal:  Circ Res       Date:  2006-08-10       Impact factor: 17.367

7.  Angiotensin-II type 1 receptor-mediated hypertension in D4 dopamine receptor-deficient mice.

Authors:  Martin J Bek; Xiaoyan Wang; Laureano D Asico; John E Jones; Shaopeng Zheng; Xiaoxi Li; Gilbert M Eisner; David K Grandy; Robert M Carey; Patricio Soares-da-Silva; Pedro A Jose
Journal:  Hypertension       Date:  2005-12-27       Impact factor: 10.190

8.  A dopamine receptor antagonist L-745,870 suppresses microglia activation in spinal cord and mitigates the progression in ALS model mice.

Authors:  Kazunori Tanaka; Yoshinori Okada; Takuya Kanno; Asako Otomo; Yoshiko Yanagisawa; Junko Shouguchi-Miyata; Etsuko Suga; Eri Kohiki; Kyuichiro Onoe; Hitoshi Osuga; Masashi Aoki; Shinji Hadano; Yasuto Itoyama; Joh-E Ikeda
Journal:  Exp Neurol       Date:  2008-03-04       Impact factor: 5.330

9.  Aminopeptidase N reduces basolateral Na+ -K+ -ATPase in proximal tubule cells.

Authors:  Kumar Kotlo; Sagar Shukla; Urmila Tawar; Randal A Skidgel; Robert S Danziger
Journal:  Am J Physiol Renal Physiol       Date:  2007-07-18

Review 10.  Dysregulation of dopamine-dependent mechanisms as a determinant of hypertension: studies in dopamine receptor knockout mice.

Authors:  Chunyu Zeng; Ines Armando; Yingjin Luo; Gilbert M Eisner; Robin A Felder; Pedro A Jose
Journal:  Am J Physiol Heart Circ Physiol       Date:  2007-12-14       Impact factor: 4.733

View more
  14 in total

Review 1.  Astrocytes and the Renin Angiotensin System: Relevance in Disease Pathogenesis.

Authors:  Ann Tenneil O'Connor; Michelle A Clark
Journal:  Neurochem Res       Date:  2018-06-01       Impact factor: 3.996

2.  Angiotensin II type 2 receptor inhibits expression and function of insulin receptor in rat renal proximal tubule cells.

Authors:  Yang Yang; Caiyu Chen; Chunjiang Fu; Zaicheng Xu; Cong Lan; Yongchun Zeng; Zhi Chen; Pedro A Jose; Ye Zhang; Chunyu Zeng
Journal:  J Am Soc Hypertens       Date:  2017-12-06

3.  Kidney dopamine D1-like receptors and angiotensin 1-7 interaction inhibits renal Na+ transporters.

Authors:  Anees A Banday; Andrea Diaz Diaz; Mustafa Lokhandwala
Journal:  Am J Physiol Renal Physiol       Date:  2019-08-14

4.  Activation of angiotensin II type 1 receptors increases D4 dopamine receptor expression in rat renal proximal tubule cells.

Authors:  Luxun Tang; Shuo Zheng; Hongmei Ren; Duofen He; Chunyu Zeng; Wei Eric Wang
Journal:  Hypertens Res       Date:  2017-02-23       Impact factor: 3.872

Review 5.  Current topics in angiotensin II type 1 receptor research: Focus on inverse agonism, receptor dimerization and biased agonism.

Authors:  Takanobu Takezako; Hamiyet Unal; Sadashiva S Karnik; Koichi Node
Journal:  Pharmacol Res       Date:  2017-06-23       Impact factor: 7.658

Review 6.  Sorting nexins: role in the regulation of blood pressure.

Authors:  Juan Huang; Andrew C Tiu; Pedro A Jose; Jian Yang
Journal:  FEBS J       Date:  2021-11-30       Impact factor: 5.622

Review 7.  Kidney tubules: intertubular, vascular, and glomerular cross-talk.

Authors:  David A Ferenbach; Joseph V Bonventre
Journal:  Curr Opin Nephrol Hypertens       Date:  2016-05       Impact factor: 2.894

Review 8.  Renal Dopamine Receptors and Oxidative Stress: Role in Hypertension.

Authors:  Jian Yang; Van Anthony M Villar; Pedro A Jose; Chunyu Zeng
Journal:  Antioxid Redox Signal       Date:  2020-05-29       Impact factor: 8.401

9.  Inhibition of D4 Dopamine Receptors on Insulin Receptor Expression and Effect in Renal Proximal Tubule Cells.

Authors:  Ye Zhang; Hongmei Ren; Xi Lu; Duofen He; Yu Han; Hongyong Wang; Chunyu Zeng; Weibin Shi
Journal:  J Am Heart Assoc       Date:  2016-04-22       Impact factor: 5.501

10.  Downregulation of Renal G Protein-Coupled Receptor Kinase Type 4 Expression via Ultrasound-Targeted Microbubble Destruction Lowers Blood Pressure in Spontaneously Hypertensive Rats.

Authors:  Hefei Huang; Xiaolong Li; Shuo Zheng; Yue Chen; Caiyu Chen; Jialiang Wang; Haipeng Tong; Lin Zhou; Jian Yang; Chunyu Zeng
Journal:  J Am Heart Assoc       Date:  2016-10-06       Impact factor: 5.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.